AA fellowship

AA fellowship occupies an unusual place in the history of psychedelic therapy. Its emphasis on spiritual awakening and surrender to a higher power is connected in the book to experiences induced by plant-derived drugs: Bill Wilson, the fellowship’s cofounder, credited a belladonna experience with his sobriety, and later investigated whether LSD could occasion comparable awakenings. His personal conviction, however, did not translate into institutional endorsement. The fellowship’s leaders feared that accepting LSD would compromise its message, leaving a consequential tension between spiritual transformation and the means proposed to bring it about.

Identity and Spiritual Framework

AA fellowship is described through the principle that a spiritual awakening can lead a person to surrender to a higher power. In the book’s account, this principle is central to the fellowship’s approach to sobriety, not an incidental feature of its history. The author draws a striking line between that framework and Bill Wilson’s experience with belladonna: Wilson attributed his own sobriety to a mystical experience brought on by the plant-derived alkaloid, administered at Towns Hospital in Manhattan in 1934.

That connection is presented as a little-known part of the fellowship’s background. The author observes that few AA members know that an experience with a hallucinogenic drug can be traced to the spiritual-awakening idea at the heart of the fellowship. The point is not that AA fellowship prescribed belladonna or was founded as a drug program, but that an experience Wilson understood as spiritually decisive helped shape the personal history behind its emphasis on awakening.

Wilson’s Interest in LSD

In the mid-1950s, Wilson learned about Humphry Osmond and Abram Hoffer’s work with alcoholics. The possibility that a drug might occasion a life-changing spiritual experience resonated with him because he associated such an experience with his own sobriety. Through Osmond, Wilson contacted Sidney Cohen, an internist who had been experimenting with LSD supplied by Sandoz since 1955.

Beginning in 1956, Wilson took part in several LSD sessions in Los Angeles with Cohen and Betty Eisner, a psychologist who had recently completed her doctorate at UCLA. The sessions convinced Wilson that LSD could reliably occasion the kind of spiritual awakening he believed necessary for sobriety. He also rejected the idea that the LSD experience was equivalent to delirium tremens, a comparison that had influenced earlier thinking about the drug and alcoholism.

Wilson’s interest was not simply a private curiosity. He considered whether LSD therapy might have a place within AA fellowship, hoping that the experience could help recovering alcoholics attain a spiritual awakening. Yet his conclusion about the potential value of LSD remained his own; the fellowship’s governing colleagues did not share his willingness to consider it.

Institutional Resistance and a Boundary Around Treatment

The fellowship’s board strongly opposed Wilson’s proposal. Its members believed that condoning the use of any mind-altering substance could muddy the organization’s identity and message. The disagreement set a clear boundary between Wilson’s belief that a drug-induced experience might support recovery and the organization’s concern about what endorsing such a substance would mean for AA fellowship.

The episode also belongs to a broader dispute over how psychedelic treatment should be understood and organized. In the 1950s, researchers developed competing models, including the idea that psychedelics resembled psychosis, the use of lower doses alongside psychoanalysis, and a model centered on a single high-dose session intended to produce a conversion experience. That latter approach challenged conventional psychiatric practice by proposing a concentrated session rather than a long course of weekly treatment, while also asking clinicians to reconsider the roles of patient and therapist. Wilson’s interest in LSD emerged amid this wider search for a therapeutic use, but the evidence does not show AA fellowship adopting any of these models.

Rediscovery and Historical Significance

Decades later, psychiatrist Stephen Ross encountered this history while researching psychedelic treatment for alcoholism. A colleague told him that LSD had been used to treat thousands of alcoholics in Canada and the United States and that Wilson had sought to introduce LSD therapy into AA fellowship. Ross was astonished that this history had scarcely reached him, despite his specialization in addiction treatment. He described finding a buried body of research: from the early 1950s, psychedelics had been studied for a range of conditions, and thousands of research participants and a large clinical literature had accumulated before the field turned against the drugs in the mid-1960s.

The rediscovery makes AA fellowship’s role neither that of a psychedelic-treatment organization nor merely that of an opponent. Wilson’s experience and advocacy reveal a personal bridge between the fellowship’s spiritual language and the therapeutic hopes attached to LSD; the board’s refusal reveals the limits of that bridge. The episode preserves a distinction the book repeatedly returns to: a spiritual awakening may be central to a recovery framework, while the institution can still reject a particular means of seeking or inducing it.